U.S. Markets closed

Vince Holding Corp. (VNCE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
7.26-0.72 (-9.02%)
At close: 4:00PM EDT
7.26 -0.12 (-1.63%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.98
Bid7.00 x 2200
Ask10.00 x 800
Day's Range7.20 - 7.92
52 Week Range3.88 - 13.51
Avg. Volume11,477
Market Cap86.383M
Beta (5Y Monthly)2.60
PE Ratio (TTM)N/A
EPS (TTM)-2.47
Earnings DateApr 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
  • Benzinga

    41 Stocks Moving In Friday's Mid-Day Session

    Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22. Echo Global Logistics, Inc. (NASDAQ: ECHO) surged 53.8% to $48.16 after the company agreed to be acquired by priva

  • Zacks

    Vince Holding Corp. (VNCE) Reports Q2 Loss, Tops Revenue Estimates

    Vince Holding Corp. (VNCE) delivered earnings and revenue surprises of 92.19% and 11.44%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Vince Holding Corp. Reports Second Quarter 2021 Results

    NEW YORK, September 09, 2021--Vince Holding Corp. (NYSE:VNCE), a leading global contemporary group ("Vince" or the "Company"), today reported its financial results for the second quarter 2021 ended July 31, 2021.